Titan Biotech Limited (TITANBIO.BO)

INR 493.55

(-0.37%)

Total Liabilities Summary of Titan Biotech Limited

Titan Biotech Limited's latest annual total liabilities in 2023 was 231.28 Million INR , down -6.0% from previous year.
Titan Biotech Limited's latest quarterly total liabilities in 2023 FY was 231.28 Million INR , down -6.0% from previous quarter.
Titan Biotech Limited reported annual total liabilities of 246.04 Million INR in 2022, down -35.23% from previous year.
Titan Biotech Limited reported annual total liabilities of 379.86 Million INR in 2021, up 34.51% from previous year.
Titan Biotech Limited reported quarterly total liabilities of 266.55 Million INR for 2023 Q2, down 0.0% from previous quarter.
Titan Biotech Limited reported quarterly total liabilities of 231.28 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Titan Biotech Limited (2023 - 2008)

Historical Annual Total Liabilities of Titan Biotech Limited (2023 - 2008)

Year	Total Liabilities	Total Liabilities Growth
2023	231.28 Million INR	-6.0%
2022	246.04 Million INR	-35.23%
2021	379.86 Million INR	34.51%
2020	282.39 Million INR	-18.13%
2019	344.94 Million INR	11.37%
2018	309.71 Million INR	-0.94%
2017	312.64 Million INR	11.47%
2016	280.46 Million INR	61.18%
2015	174 Million INR	33.52%
2014	130.32 Million INR	3.77%
2013	125.58 Million INR	60.22%
2012	78.38 Million INR	0.87%
2011	77.7 Million INR	35.29%
2010	57.43 Million INR	120.07%
2009	26.09 Million INR	18.2%
2008	22.08 Million INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q3	- INR	-100.0%
2023 Q2	266.55 Million INR	0.0%
2023 Q4	231.28 Million INR	0.0%
2023 FY	231.28 Million INR	-6.0%
2023 Q1	- INR	-100.0%
2022 Q4	246.04 Million INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	220.81 Million INR	15.38%
2022 Q1	191.38 Million INR	-49.62%
2022 FY	246.04 Million INR	-35.23%
2021 Q2	268.06 Million INR	-18.67%
2021 Q1	329.58 Million INR	16.71%
2021 FY	379.86 Million INR	34.51%
2021 Q4	379.86 Million INR	16.87%
2021 Q3	325.04 Million INR	21.25%
2020 Q1	392.58 Million INR	13.81%
2020 Q3	266.72 Million INR	-27.57%
2020 FY	282.39 Million INR	-18.13%
2020 Q4	282.39 Million INR	5.87%
2020 Q2	368.24 Million INR	-6.2%
2019 Q2	303.03 Million INR	0.0%
2019 FY	344.94 Million INR	11.37%
2019 Q4	344.94 Million INR	0.0%
2018 Q2	318.7 Million INR	0.0%
2018 FY	309.71 Million INR	-0.94%
2018 Q4	309.71 Million INR	0.0%
2017 Q4	312.64 Million INR	0.0%
2017 FY	312.64 Million INR	11.47%
2017 Q2	344.66 Million INR	0.0%
2016 Q2	188.21 Million INR	0.0%
2016 FY	280.46 Million INR	61.18%
2016 Q4	280.46 Million INR	0.0%
2015 Q4	174 Million INR	0.0%
2015 Q2	119.08 Million INR	0.0%
2015 FY	174 Million INR	33.52%
2014 Q4	130.32 Million INR	0.0%
2014 FY	130.32 Million INR	3.77%
2013 FY	125.58 Million INR	60.22%
2013 Q2	101.1 Million INR	0.0%
2013 Q4	125.58 Million INR	0.0%
2012 Q4	78.38 Million INR	0.0%
2012 FY	78.38 Million INR	0.87%
2011 FY	77.7 Million INR	35.29%
2011 Q4	77.7 Million INR	0.0%
2010 FY	57.43 Million INR	120.07%
2010 Q4	57.43 Million INR	0.0%
2009 FY	26.09 Million INR	18.2%
2008 FY	22.08 Million INR	0.0%
2008 Q4	22.08 Million INR	0.0%

Peer Total Liabilities Comparison of Titan Biotech Limited

Name	Total Liabilities	Total Liabilities Difference
Alfavision Overseas (India) Limited	1.36 Billion INR	83.067%
Biocon Limited	307.95 Billion INR	99.925%
Blue Jet Healthcare Limited	2.13 Billion INR	89.173%
Concord Biotech Limited	1.74 Billion INR	86.712%
Dishman Carbogen Amcis Limited	39.53 Billion INR	99.415%
FERMENTA BIOTECH LIMITED	2.62 Billion INR	91.195%
GENOMIC VALLEY BIOTECH LIMITED	7.91 Million INR	-2821.721%
Lyka Labs Limited	884.58 Million INR	73.854%
Panacea Biotec Limited	4.02 Billion INR	94.247%
SAMSRITA LABS LIMITED	32.93 Million INR	-602.253%
Servoteach Industries Limited	5275.00 INR	-4384487.678%
SMS Lifesciences India Limited	1.96 Billion INR	88.253%
Supriya Lifescience Limited	1.05 Billion INR	78.154%
Syngene International Limited	18.93 Billion INR	98.779%
TAKE Solutions Limited	969.78 Million INR	76.151%
Transgene Biotek Limited	393.11 Million INR	41.165%
Vanta Bioscience Limited	724.23 Million INR	68.065%